Document is current
Any future updates will be listed below
-
Authors
Ettl, Johannes https://orcid.org/0000-0003-4754-8447
Anders, Sophie-Isabelle
Hapfelmeier, Alexander
Paepke, Stefan
Noske, Aurelia
Weichert, Wilko
Klein, Evelyn
Kiechle, Marion
-
Funding
Funding for this research was provided by:
Technische Universität München
- License Information
-
More Information
Article History
Received: 6 July 2020
Accepted: 24 August 2020
First Online: 9 September 2020
Compliance with ethical standards
:
: JE received honoraria from Astra Zeneca, Daiichy, Roche, Celgene, Novartis, Lilly, Pfizer, Pierre Fabre, Tesaro, TEVA and travel support from Astra, Celgene, Lilly, Novartis, Pfizer, Tesoro. WW received research funding (BMS,MSD, Roche) and had consulting or advisory role (Amgen, Astellas,AZ,BMS, Boehringer, Merck,MSD, Pfizer, Roche, Takeda, Lilly, Novartis). MK received remuneration from Springer Press, Biermann Press, Celgene, AstraZeneca, Myriad Genetics, and Teva, received consultancy or advisory fees from Myriad Genetics, KVB, DKMS LIFE, BLÄK, and TEVA, holds stock in Therawis Diagnostics GmbH and Busenfreundin GmbH, and received funding from Sphingotec, Deutsche Krebshilfe, DFG, Senator Roesner Foundation, and Dr. Pommer-Jung Foundation. SP received consulting fees from MSD, Medtronic, mbp, HC21, pfm medical ag, Novusscientific, Sysmex Deutschland GmBH, Invitrocue Europe GmBH and educational funding from Roche. The remaining authors (AN, SIA, AH, EK) have no competing interest to declare.
: This study has been approved by the ethics committee of the faculty of medicine at Klinikum rechts der Isar, Technical University of Munich (311/16s). Informed consent was waived.
